Astrazeneca plc has returned to China’s CSPC Pharmaceutical Group Ltd. for another discovery collaboration, this time in a ...

Vera Therapeutics Inc. looks to get an almost five-month head start over a competitor, Vertex Pharmaceuticals Inc., as the U.S. FDA cleared its Trutakna (atacicept) as the first dual BAFF/APRIL ...

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev ...

Vertex Pharmaceuticals Inc. is buying Crinetics Pharmaceuticals Inc. for $85 per share in cash, which translates to about $10 billion in equity value. Both boards approved the transaction, expected to ...

Researchers in Korea have investigated the interaction of SET-domain containing 1B (SET1B) with other proteins in vitro, as well as the impact of SET1B depletion in hepatocellular carcinoma cell lines ...

Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and more potent class of payload. With ...

Resurrecting a reimbursement rule on 340B drugs that the U.S. Supreme Court struck down in 2021, CMS is once again proposing ...

The top 10 biopharma stock gainers and losers for the week.

Children’s Hospital of Fudan University, Sydney Children’s Hospital and the University of Sydney have jointly patented new antibody-drug conjugates comprising an antibody targeting GD2 ganglioside ...

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in ...

Some proteins embedded in the structure of prions may have antimicrobial activity, according to a study led by scientists at ...

Ipsen SA announced its second acquisition of the week, saying it will pay €700 million (US$797 million) for Memo Therapeutics ...